Predicting gastric cancer survival using machine learning: A systematic review.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
[METHODS] A comprehensive search of PubMed and Web of Science in November 2024 identified 16 relevant studies published after 2019.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
These results highlight the potential of ML-based models to improve clinical practice by enabling personalized treatment planning and risk stratification. [CONCLUSION] Despite challenges concerning retrospective studies and a lack of interpretability, ML models show promise; prospective trials and multidimensional data integration are recommended for improving their clinical applicability.
[BACKGROUND] Gastric cancer (GC) has a poor prognosis, and the accurate prediction of patient survival remains a significant challenge in oncology.
APA
Wang HN, An JH, et al. (2025). Predicting gastric cancer survival using machine learning: A systematic review.. World journal of gastrointestinal oncology, 17(5), 103804. https://doi.org/10.4251/wjgo.v17.i5.103804
MLA
Wang HN, et al.. "Predicting gastric cancer survival using machine learning: A systematic review.." World journal of gastrointestinal oncology, vol. 17, no. 5, 2025, pp. 103804.
PMID
40487963 ↗
Abstract 한글 요약
[BACKGROUND] Gastric cancer (GC) has a poor prognosis, and the accurate prediction of patient survival remains a significant challenge in oncology. Machine learning (ML) has emerged as a promising tool for survival prediction, though concerns regarding model interpretability, reliance on retrospective data, and variability in performance persist.
[AIM] To evaluate ML applications in predicting GC survival and to highlight key limitations in current methods.
[METHODS] A comprehensive search of PubMed and Web of Science in November 2024 identified 16 relevant studies published after 2019. The most frequently used ML models were deep learning (37.5%), random forests (37.5%), support vector machines (31.25%), and ensemble methods (18.75%). The dataset sizes varied from 134 to 14177 patients, with nine studies incorporating external validation.
[RESULTS] The reported area under the curve values were 0.669-0.980 for overall survival, 0.920-0.960 for cancer-specific survival, and 0.710-0.856 for disease-free survival. These results highlight the potential of ML-based models to improve clinical practice by enabling personalized treatment planning and risk stratification.
[CONCLUSION] Despite challenges concerning retrospective studies and a lack of interpretability, ML models show promise; prospective trials and multidimensional data integration are recommended for improving their clinical applicability.
[AIM] To evaluate ML applications in predicting GC survival and to highlight key limitations in current methods.
[METHODS] A comprehensive search of PubMed and Web of Science in November 2024 identified 16 relevant studies published after 2019. The most frequently used ML models were deep learning (37.5%), random forests (37.5%), support vector machines (31.25%), and ensemble methods (18.75%). The dataset sizes varied from 134 to 14177 patients, with nine studies incorporating external validation.
[RESULTS] The reported area under the curve values were 0.669-0.980 for overall survival, 0.920-0.960 for cancer-specific survival, and 0.710-0.856 for disease-free survival. These results highlight the potential of ML-based models to improve clinical practice by enabling personalized treatment planning and risk stratification.
[CONCLUSION] Despite challenges concerning retrospective studies and a lack of interpretability, ML models show promise; prospective trials and multidimensional data integration are recommended for improving their clinical applicability.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.
- LCMS-Net: Deep Learning for Raw High Resolution Mass Spectrometry Data Applied to Forensic Cause-of-Death Screening.
- Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in -amplified gastric cancer.
- Association of preoperative frailty and prognostic nutritional index with postoperative delirium in elderly gastric cancer patients: A single-center observational study.